Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. The company was incorporated in 1994 and is headquartered in Shanghai, China.
Metrics to compare | SHPMY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSHPMYPeersSector | |
---|---|---|---|---|
P/E Ratio | 14.5x | 17.5x | −0.5x | |
PEG Ratio | 1.05 | −0.26 | 0.00 | |
Price/Book | 0.9x | 1.2x | 2.6x | |
Price / LTM Sales | 0.2x | 0.7x | 3.2x | |
Upside (Analyst Target) | - | 19.8% | 46.0% | |
Fair Value Upside | Unlock | 26.2% | 6.3% | Unlock |